12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers GT Biopharma (NASDAQ:GTBP) stock rose 153.2% to $7.9 during Monday’s pre-market session. The company’s market cap stands…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Akso Health Group (NASDAQ:AHG) shares rose 11.4% to $0.79 during Friday’s after-market session. The company’s market cap…
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday’s regular session. The company’s market cap stands at…
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday’s after-market session. The company’s market…
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers INVO Bioscience (NASDAQ:INVO) stock rose 275.0% to $2.85 during Wednesday’s regular session. The market value of their…
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers INVO Bioscience (NASDAQ:INVO) shares increased by 93.4% to $1.47 during Wednesday’s pre-market session. The market value of…
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Clene (NASDAQ:CLNN) shares moved upwards by 54.9% to $0.48 during Tuesday’s after-market session. The company’s market cap…
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.